Nisin Market Growth Analysis by Applications, Trends, Size and Outlook Till 2027

The Global Nisin Market was valued at US$ 489.58 million in 2016 and is expected to reach US$ 732.10 million by 2025, witnessing a CAGR of 4.6% over the forecast period (2017-2025). According to a Nisin Market Report, by Application (Meat, Beverages, Dairy Products, Bakery Products, Canned Vegetables, and Others). Nisin is a bacteriocin, majorly produced by gram positive bacteria such as Lactococcus lactis. It shows antimicrobial activity against food-borne bacteria such as Clostridium botulinum, Staphylococcus aureus, and Listeria monocytogenes at low concentration. It shows synergistic action with other bacteriocins and chelators. Nisin plays an immune-modulatory role, offering anti-biofilm and anti-cancer properties. Growing application of nisin in bio preservation of dairy products such as yoghurt, natural cheese, processed cheese, egg products, pasteurized soups, flour-based products, canned food such as peas, okra, asparagus, mushrooms, peppers, and carrots, and meat products such as sausages, seafood, and salad dressings, and alcoholic beverages such as wine and beer are driving growth of the nisin market.
Browse 500 pages, 200 market data tables* and 50 figures* on ""Nisin Market" - Global forecast to 2025.
Key Trends and Analysis of the Nisin Market:
• Among applications, the meat segment accounted for the highest market share in 2016. Nisin is replacing sodium nitrate, which is commonly used for meat preservation. The consumption of sodium nitrate causes health hazards such as blue baby syndrome for infants and toddlers, also increasing the risk of cancer. Meat is a source of essential vitamins, proteins, and minerals that are essential for good health. The benefits of meat consumption such as elimination of skin diseases and strengthening of immunity are propelling growth of the meat market. According to the thirteenth joint edition of the OECD-FAO Agricultural Outlook, the global meat production is estimated to expand to around 48 Mt by 2025, especially in emerging economies that are expected to account for around 73% of the additional output. Also, the meat production is expected to increase by 16% in 2025. Thus, increasing application of nisin for meat preservation coupled with the significant growth in the meat market is driving growth of the meat segment.
• Nisin is the only bacteriocin approved by U.S. Food and Drug Administration and World Health Organization for use as a food preservative. The Joint Food and Agriculture Organization/World Health Organization (FAO/WHO) approved nisin as safe food additive in 1969. The FDA approved nisin in 1988 to inhibit growth of Clostridium botulinum and recognized it as generally regarded as safe (GRAS). It is a registered food preservative in over 50 countries and is used as a natural preservative in various types of food.
Key Takeaways of the Market:
• According to Coherent Market Insights study, North America accounted for the largest market share of 34.69% in terms of revenue in the global nisin market in 2016.This is attributed to the increasing demand for less processed convenience food with longer shelf-life, growing awareness regarding health hazards of synthetic preservatives, and stringent regulatory requirements imposed by the U.S. Food and Drug Administration.
• Asia Pacific is the fastest growing market, owing to growing demand for preservatives in the rapidly growing meat, dairy, and food processing industries. According to the Union Budget 2017-18, the Government of India has invested US$ 1.2 billion on dairy processing. Also, the Confederation of Indian Industry (CII) estimated that the food processing sector to attract US$ 33 billion of investment by the following decade. Such investments are expected to increase growth of the preservatives market in India, which in turn, is expected to augment growth of the nisin market in Asia Pacific.
• Key players operating in the global Nisin market include Amtech Biotech Co., Ltd, Chihon Biotechnology Co., Ltd., Cayman Chemical, Danisco A/S, DSM N.V., Galactic, Handary S.A., Royal, Sivelee B.V., Shandong Freda Biotechnology Co., and Zhejiang Silver-Elephant Bio-engineering Co. Ltd.